LAWRENCE, Mass., Feb. 21, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced CE Mark approval for new high flow capabilities with the NxStage System One™. With this approval, the Company expects to bring this advancement to customers in countries that recognize the CE Mark approval process later this year.